Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: J Immunol. 2017 Feb 27;198(7):2735–2746. doi: 10.4049/jimmunol.1600810

Figure 6. OXPHOS inhibition reduces TH17 cytokine production.

Figure 6

(A–F) In vivo (red)- or in vitro (blue)-differentiated TH17 cells were treated for one hour with DMSO or the indicated concentration of oligomycin and then stimulated with PMA/ionomycin. IL-17 expression was analyzed by FACS (A). The production of IL-17a, GM-CSF, TNF, and IL-21 in cell-free supernatant from triplicate cultures was evaluated by ELISA (BF). (A–F) Results are expressed as percentage of DMSO-treated cells. (A) For in vivo TH17, each dot represents an individual mouse; for in vitro TH17, an independent cell culture. (AF) Representative of three independent experiments; *p < 0.001; N.S., not significant (A: paired Student’s t-test; B–F: unpaired Student’s t-test); error bars, mean ± SEM.